BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9293505)

  • 21. Imaging of brain tumors in AIDS patients by means of dual-isotope thallium-201 and technetium-99m sestamibi single-photon emission tomography.
    De La Peña RC; Ketonen L; Villanueva-Meyer J
    Eur J Nucl Med; 1998 Oct; 25(10):1404-11. PubMed ID: 9818280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment.
    Yoshii Y; Satou M; Yamamoto T; Yamada Y; Hyodo A; Nose T; Ishikawa H; Hatakeyama R
    Eur J Nucl Med; 1993 Jan; 20(1):39-45. PubMed ID: 8420781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Brain SPECT with 201-thallium in AIDS patients].
    Gallardo FG; Moreno V; Babe J; Cobo J; Ríos M; Gómez MV
    Rev Esp Med Nucl; 2001 Oct; 20(6):439-42. PubMed ID: 11578578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of thallium-201 brain uptake in progressive multifocal leukoencephalopathy in AIDS patients.
    Iranzo A; Martí-Fábregas J; Domingo P; Catafau A; Molet J; Moreno A; Pujol J; Matias-Guiu X; Cadafalch J
    Acta Neurol Scand; 1999 Aug; 100(2):102-5. PubMed ID: 10442451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear medicine applications in immunosuppressed patients, "AIDS".
    Abdel-Dayem HM
    Ann Nucl Med; 1996 Nov; 10(4):369-73. PubMed ID: 9006720
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of sequential thallium and gallium scans of the chest in AIDS patients.
    Abdel-Dayem HM; Bag R; DiFabrizio L; Aras T; Turoglu HT; Kempf JS; Habbab N; Pescatore F; Sadik A; Kowalsky W
    J Nucl Med; 1996 Oct; 37(10):1662-7. PubMed ID: 8862304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CT assessment of CNS complications of AIDS.
    Wilson BG
    Radiol Technol; 2002; 73(5):424-37; quiz 438-40. PubMed ID: 12048982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cerebral toxoplasmosis. Neuroradiologic diagnosis and prognostic monitoring].
    Martin-Duverneuil N; Cordoliani YS; Sola-Martinez MT; Miaux Y; Weill A; Chiras J
    J Neuroradiol; 1995 Sep; 22(3):196-203. PubMed ID: 7472537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TI-201 chloride and Tc-99m ECD brain SPECT in lymphoma with and without massive necrosis.
    Shih WJ; McCormick MI; Wilson D
    Clin Nucl Med; 1997 Jun; 22(6):427-30. PubMed ID: 9193829
    [No Abstract]   [Full Text] [Related]  

  • 30. Intracranial mass lesions: sequential thallium and gallium scintigraphy in patients with AIDS.
    Lee VW; Antonacci V; Tilak S; Fuller JD; Cooley TP
    Radiology; 1999 May; 211(2):507-12. PubMed ID: 10228535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.
    Sonoda Y; Kumabe T; Takahashi T; Shirane R; Yoshimoto T
    Neurol Med Chir (Tokyo); 1998 Jun; 38(6):342-7; discussion 347-8. PubMed ID: 9689817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary cerebral lymphoma in 10 patients with AIDS. Comparative clinico-radiologic study with cerebral toxoplasmosis, cerebral tuberculoma and primary cerebral lymphoma in non-immunodepressed patients].
    Arbaiza D; Pujol M; Conde C; Abós J; Miró JM; Mercader JM; Ribalta T; Graus F
    Med Clin (Barc); 1992 Jun; 99(4):128-31. PubMed ID: 1635405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of fluorodeoxyglucose-positron emission tomography for the differentiation of cerebral lesions in patients with acquired immune deficiency syndrome.
    Menendez JA; Lilien DL; Nanda A; Polin RS
    Neurosurg Focus; 2000 Feb; 8(2):e2. PubMed ID: 16869549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False-negative single-photon emission CT in AIDS lymphoma: lack of effect of steroids.
    Campbell BG; Hurley J; Zimmerman RD
    AJNR Am J Neuroradiol; 1996 May; 17(5):1000-2. PubMed ID: 8733980
    [No Abstract]   [Full Text] [Related]  

  • 35. Sequential scintigraphic strategy for the differentiation of brain tumours.
    Matheja P; Rickert C; Weckesser M; Palkovic S; Löttgen J; Riemann B; Kopka K; Kuwert T; Wassmann H; Paulus W; Schober O
    Eur J Nucl Med; 2000 May; 27(5):550-8. PubMed ID: 10853811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thallium-201 brain SPECT of lymphoma in AIDS patients: pitfalls and technique optimization.
    Kessler LS; Ruiz A; Donovan Post MJ; Ganz WI; Brandon AH; Foss JN
    AJNR Am J Neuroradiol; 1998; 19(6):1105-9. PubMed ID: 9672019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of cerebral SPECT with thallium-201 in the diagnosis of primary cerebral lymphoma in AIDS].
    Romeu J; Fraile M; de las Heras P; García O
    Med Clin (Barc); 1995 Sep; 105(7):275. PubMed ID: 7475471
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical relevance of 201Tl-chloride SPET in the differential diagnosis of brain tumours.
    Staffen W; Hondl N; Trinka E; Iglseder B; Unterrainer J; Ladurner G
    Nucl Med Commun; 1998 Apr; 19(4):335-40. PubMed ID: 9853323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management protocol for an enhancing cerebral lesion in HIV infection.
    Finelli PF
    Conn Med; 1996 Nov; 60(11):649-51. PubMed ID: 8979431
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of glioma viability by estimating 201Tl SPET tumour uptake volume.
    Källén K; Geijer B; Andersson AM; Holtås S; Ryding E; Rosén I
    Nucl Med Commun; 1999 Sep; 20(9):837-44. PubMed ID: 10533190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.